{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T04:34:11Z","timestamp":1721104451612},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T00:00:00Z","timestamp":1390435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T00:00:00Z","timestamp":1390435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s12029-014-9578-y","type":"journal-article","created":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T08:17:39Z","timestamp":1390378659000},"page":"268-275","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Phase II Trial of Adjuvant Oral Thalidomide Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Disease from Colorectal\/Appendiceal Cancer"],"prefix":"10.1007","volume":"45","author":[{"given":"Perry","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher R.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce","family":"Fenstermaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mebea","family":"Aklilu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas P.","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward A.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,23]]},"reference":[{"key":"9578_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/jso.2930220208","volume":"22","author":"LE Dawson","year":"1983","unstructured":"Dawson LE, Russell AH, Tong D, et al. Adenocarcinoma of the sigmoid colon: sites of initial dissemination and clinical patterns of recurrence following surgery alone. J Surg Oncol. 1983;22:95\u20139.","journal-title":"J Surg Oncol"},{"key":"9578_CR2","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1002\/1097-0142(19890115)63:2<364::AID-CNCR2820630228>3.0.CO;2-V","volume":"63","author":"DZ Chu","year":"1989","unstructured":"Chu DZ, Lang NP, Thompson C, et al. PSD in nongynecologic malignancy: a prospective study of prognostic factors. Cancer. 1989;63:3643\u201367.","journal-title":"Cancer"},{"issue":"4 Suppl 6","key":"9578_CR3","first-page":"83","volume":"16","author":"PH Sugarbaker","year":"1989","unstructured":"Sugarbaker PH, Cunliffe WJ, Belliveau J, et al. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol. 1989;16(4 Suppl 6):83\u201397.","journal-title":"Semin Oncol"},{"key":"9578_CR4","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/1097-0142(19900401)65:7<1495::AID-CNCR2820650708>3.0.CO;2-1","volume":"65","author":"PH Sugarbaker","year":"1990","unstructured":"Sugarbaker PH, Landy D, Jaffe G, et al. Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with PSD from cystadenocarcinoma of the colon or appendix. Cancer. 1990;65:1495\u2013501.","journal-title":"Cancer"},{"issue":"5","key":"9578_CR5","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s10434-006-9708-2","volume":"13","author":"JH Stewart 4th","year":"2006","unstructured":"Stewart 4th JH, Shen P, Russell GB, et al. Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Ann Surg Oncol. 2006;13(5):624\u201334.","journal-title":"Ann Surg Oncol"},{"key":"9578_CR6","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.currproblcancer.2009.06.004","volume":"33","author":"P Shen","year":"2009","unstructured":"Shen P, Stewart 4th JH, Levine EA. The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer with peritoneal surface disease. Curr Probl Cancer. 2009;33:154\u201367.","journal-title":"Curr Probl Cancer"},{"issue":"26","key":"9578_CR7","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1056\/NEJM199512283332608","volume":"333","author":"J Folkman","year":"1995","unstructured":"Folkman J. Clinical applications of research on angiogenesis. N Engl J Med. 1995;333(26):1757\u201363.","journal-title":"N Engl J Med"},{"issue":"1","key":"9578_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0960-9822(95)00004-2","volume":"5","author":"R Vile","year":"1995","unstructured":"Vile R. Cancer therapy. Less blood means more sanguinity. Curr Biol. 1995;5(1):10\u20133.","journal-title":"Curr Biol"},{"issue":"7\/8","key":"9578_CR9","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/0959-8049(95)00169-J","volume":"31A","author":"A Bikfalvi","year":"1995","unstructured":"Bikfalvi A. Significance of angiogenesis in tumour progression and metastasis. Eur J Cancer. 1995;31A(7\/8):1101\u20134.","journal-title":"Eur J Cancer"},{"key":"9578_CR10","first-page":"217","volume":"26","author":"R Or","year":"1998","unstructured":"Or R, Feferman R, Shoshan S. Thalidomide reduces vascular density in granulation tissue of subcutaneously implanted polyvinyl alcohol sponges in guinea pigs. Exp Hematol. 1998;26:217\u201321.","journal-title":"Exp Hematol"},{"key":"9578_CR11","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1006\/exer.1997.0292","volume":"64","author":"B Kenyon","year":"1997","unstructured":"Kenyon B, Browne F, D\u2019Amato R. Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization. Exp Eye Res. 1997;64:971\u20138.","journal-title":"Exp Eye Res"},{"key":"9578_CR12","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1245\/ASO.2005.12.001","volume":"12","author":"JH Stewart 4th","year":"2005","unstructured":"Stewart 4th JH, Shen P, Levine EA. Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions. Ann Surg Oncol. 2005;12:765\u201377.","journal-title":"Ann Surg Oncol"},{"key":"9578_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Calvien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg"},{"issue":"16","key":"9578_CR14","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","volume":"22","author":"O Glehen","year":"2004","unstructured":"Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of PSD from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22(16):3284\u201392.","journal-title":"J Clin Oncol"},{"key":"9578_CR15","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","volume":"88","author":"B Sadeghi","year":"2000","unstructured":"Sadeghi B, Arvieux C, Glehen O, et al. PSD from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88:358\u201363.","journal-title":"Cancer"},{"key":"9578_CR16","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, Van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with PSD of colorectal cancer. J Clin Oncol. 2003;21:3737\u201343.","journal-title":"J Clin Oncol"},{"key":"9578_CR17","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1200\/JCO.2002.99.155","volume":"20","author":"N Abramson","year":"2002","unstructured":"Abramson N, Stokes PK, Luke M, et al. Ovarian and papillary-serous peritoneal carcinoma: pilot study with thalidomide. J Clin Oncol. 2002;20:1147\u20139.","journal-title":"J Clin Oncol"},{"key":"9578_CR18","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.ygyno.2006.05.035","volume":"103","author":"JK Chan","year":"2006","unstructured":"Chan JK, Manuel MR, Ciaravino G, et al. Safety and efficacy of thalidomide in recurrent epithelial ovarian and peritoneal carcinoma. Gynecol Oncol. 2006;103:919\u201323.","journal-title":"Gynecol Oncol"},{"key":"9578_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1023\/A:1025485031112","volume":"21","author":"LD Lago","year":"2003","unstructured":"Lago LD, Richter MF, Cancela AI, et al. Phase II trial and pharmacokinetic study of thalidomide in patients with metastatic colorectal cancer. Invest New Drugs. 2003;21:359\u201366.","journal-title":"Invest New Drugs"},{"key":"9578_CR20","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1182\/blood-2007-10-117457","volume":"111","author":"A Palumbo","year":"2008","unstructured":"Palumbo A, Facon T, Sonneveld P, et al. Thalidomide for the treatment of multiple myeloma: 10\u00a0years later. Blood. 2008;111:3968\u201377.","journal-title":"Blood"},{"key":"9578_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1046\/j.1538-7933.2003.00573.x","volume":"2","author":"V Kaushal","year":"2004","unstructured":"Kaushal V, Kaushal GP, Melkaveri SN, et al. Thalidomide protects endothelial cells from doxorubicin-induced apoptosis but alters cell morphology. J Thromb Haemost. 2004;2:327\u201334.","journal-title":"J Thromb Haemost"},{"key":"9578_CR22","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/sj.leu.2402866","volume":"17","author":"SV Rajkumar","year":"2003","unstructured":"Rajkumar SV, Gertz MA, Lacy MQ, et al. Thalidomide as initial therapy for early-stage myeloma. Leukemia. 2003;17:775\u20139.","journal-title":"Leukemia"},{"issue":"1","key":"9578_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/1097-0142(20010701)92:1<85::AID-CNCR1295>3.0.CO;2-R","volume":"92","author":"BM Ronnett","year":"2001","unstructured":"Ronnett BM, Yan H, Sugarbaker PH, et al. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous surface disease. Cancer. 2001;92(1):85\u201391.","journal-title":"Cancer"},{"key":"9578_CR24","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1200\/JCO.2006.07.1142","volume":"24","author":"TD Yan","year":"2006","unstructured":"Yan TD, Black D, Savady R, et al. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for PSD from colorectal carcinoma. J Clin Oncol. 2006;24:4011\u20139.","journal-title":"J Clin Oncol"},{"key":"9578_CR25","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jamcollsurg.2006.12.048","volume":"204","author":"EA Levine","year":"2007","unstructured":"Levine EA, Stewart 4th JH, Russell GB, et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures. J Am Coll Surg. 2007;204:943\u201355.","journal-title":"J Am Coll Surg"},{"key":"9578_CR26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1245\/ASO.2004.05.009","volume":"11","author":"P Shen","year":"2004","unstructured":"Shen P, Hawksworth J, Lovato J, et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol. 2004;11:178\u201386.","journal-title":"Ann Surg Oncol"},{"key":"9578_CR27","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1634\/theoncologist.2008-0083","volume":"13","author":"BH O\u2019Neil","year":"2008","unstructured":"O\u2019Neil BH, Goldberg RM. Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials. Oncologist. 2008;13:1074\u201383.","journal-title":"Oncologist"},{"key":"9578_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","volume":"30","author":"J Franko","year":"2012","unstructured":"Franko J, Shi Q, Goldman CD, et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol. 2012;30:263\u20137.","journal-title":"J Clin Oncol"},{"key":"9578_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1200\/JCO.2010.30.0855","volume":"29","author":"CJ Allegra","year":"2011","unstructured":"Allegra CJ, Yothers G, O\u2019Connell MJ, et al. Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08. J Clin Oncol. 2011;29:11\u20136.","journal-title":"J Clin Oncol"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-014-9578-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-014-9578-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-014-9578-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-014-9578-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T10:44:04Z","timestamp":1628592244000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-014-9578-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,23]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["9578"],"URL":"https:\/\/doi.org\/10.1007\/s12029-014-9578-y","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,23]]},"assertion":[{"value":"23 January 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}